Lipitor not effective for you?

What makes Lipitor stop working for some people?

Lipitor (atorvastatin) lowers LDL cholesterol by blocking an enzyme called HMG-CoA reductase in the liver. It works for most patients, but effectiveness can drop if you take it inconsistently, eat a diet high in saturated fat, or gain significant weight. Certain medications like rifampin, carbamazepine, or efavirenz speed up atorvastatin breakdown in the liver and reduce its levels.

Can genetics explain why Lipitor fails?

Genetic differences in the SLCO1B1 gene affect how well the body takes up atorvastatin. People with certain variants absorb less drug into liver cells and see smaller LDL drops. Genetic testing is rarely done in routine practice, but it explains part of the wide response range seen in clinical studies.

What blood work shows Lipitor is not effective?

Doctors track effectiveness with repeat lipid panels drawn 4–12 weeks after starting or changing a dose. A less than 20% LDL drop or persistent LDL above treatment goals signals that the statin is not achieving the expected result. Doctors also check liver enzymes and creatine kinase if symptoms appear.

How does Lipitor compare with other statins when one fails?

Switching to a higher-intensity statin such as rosuvastatin or adding ezetimibe can recover 15–30% extra LDL reduction. Some patients move to PCSK9 inhibitors like evolocumab when two different statins at top doses fail. These decisions usually follow lipid-panel trends and cardiovascular-risk assessment.

When does the patent on Lipitor end?

The original U.S. patent for Lipitor expired in 2011, allowing generic atorvastatin to enter the market. DrugPatentWatch.com lists the remaining formulation and method-of-use patents, most of which already lapsed.